Across the recent three months, 7 analysts have shared their insights on Krystal Biotech (NASDAQ:KRYS), expressing a variety of opinions spanning from bullish to bearish. The following table ...

Hera Biotech, the leader in definitive, non-invasive women’s health detection and staging for endometriosis, announced today its acquisition of HeraFem®, a p ...

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and billions of newly identified genes – but even this trove of data may ...

The Massachusetts biotech industry produces an astonishing 15 percent of the entire US drug development pipeline and employs nearly 117,000 people in high-skilled jobs.

Biotech Boomtown: Investments flourish in Triangle's life sciences industry By Michael Perchick, via Wednesday, June 11, 2025 ...

The annual Biotechnology Innovation Organization trade show is expected to bring about 20,000 participants to Boston starting on Monday. Here are the expected key topics of discussion.

The European Commission (EC) began a call for evidence on May 14, 2025, for an impact assessment of the European Biotech Act. The EC states that the overall objective is to improve the size and ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more selective.

Biotech Stocks Cash in on the biotech boom with three promising European picks Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other industries as biotechnology has delivered only subpar investor returns.

Bay Area biotech company Synthego, after raising $392 million, forced into bankruptcy Synthego, which develops gene editing tools for researchers, has a plan in place to sell to a hedge fund ...

Two biotech stocks make perfect candidates for this sort of strategy right now. One has declined over the past four years, while the other just slipped in recent weeks.